Research
Sensory Horizons and the Functions of Conscious Vision.
The Behavioral and brain sciences – April 21, 2025
Summary
Our visual consciousness operates with surprising slowness, taking up to 400 milliseconds to process what we see. This delay allows our brains to integrate information across sensory horizons - a feature that evolved as animals transitioned from water to land. Wider terrestrial vision enabled advanced cognition and conscious planning, while unconscious processes handled immediate reactions.
Abstract
It is not obvious why we are conscious. Why can't all of our mental activities take place unconsciously? What is consciousness for? We aim to make ...
Tusi use among the New York City nightclub-attending population.
Addiction (Abingdon, England) – April 20, 2025
Summary
Pink cocaine, known as Tusi, is gaining popularity in NYC nightlife, with 2.7% of dance club attendees reporting use in the past year. Through saliva testing and self-report surveys, researchers found Hispanic partygoers were 5x more likely to use this drug mixture. Many users unknowingly consumed ketamine and other party drugs, highlighting risks in the nightlife scene.
Abstract
'Tusi', also known as 'tusibí' or 'pink cocaine', is a drug concoction which previously emerged in Latin America and Europe and has recently acquir...
Biotransformation of ketamine in terminal in vivo experiments under chronic intermittent hypoxia conditions and the role of AhR.
Archives of toxicology – April 19, 2025
Summary
New insights into how sleep apnea affects drug metabolism reveal that oxygen fluctuations can alter how anesthesia medications break down in the body. Scientists found that low oxygen conditions change how ketamine is processed, particularly through the aryl hydrocarbon receptor pathway. This discovery has implications for improving anesthesia safety in patients with sleep-related breathing disorders.
Abstract
We were pioneers in describing aryl hydrocarbon receptor (AhR) activation by chronic intermittent hypoxia (CIH) in a rat pre-clinical model. This m...
Ketamine-induced static and dynamic functional connectivity changes are modulated by opioid receptors and biological sex in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology – April 19, 2025
Summary
Ketamine's rapid antidepressant effects may work differently in males and females, with surprising involvement from the brain's opioid system. New research reveals that blocking opioid receptors changes how ketamine affects brain connectivity patterns, particularly in male rats. These changes were most notable in the prefrontal cortex, a key region for mood regulation, suggesting that ketamine's therapeutic benefits may rely partly on opioid system interaction.
Abstract
Subanesthetic ketamine is currently used as a rapid-acting treatment for varied neuropsychiatric disorders. However, the mechanistic underpinnings ...
Research progress of postoperative delirium in neurosurgery.
World journal of psychiatry – April 19, 2025
Summary
Up to 30% of patients experience mental confusion after brain surgery. Recent advances reveal that postoperative delirium, a temporary state of confusion and disorientation, can be better predicted and managed through targeted interventions. Early recognition of risk factors, including age and pre-existing neurological dysfunction, combined with specialized surgical protocols, has led to improved recovery outcomes and shorter hospital stays.
Abstract
Delirium is a transient and acute syndrome of encephalopathy, characterized by disturbances in consciousness, orientation, cognition, perception, a...
Healthy Pills: A Physical Activity and Meditation Program to Enhance Mental Health and Well-Being in Spanish University Students.
Behavioral sciences (Basel, Switzerland) – April 18, 2025
Summary
No Summary
Abstract
(1) Background: University students' mental health (MH) is in crisis due to academic stress, lack of physical activity (PA), and low self-esteem. T...
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials.
Journal of psychoactive drugs – April 18, 2025
Summary
Groundbreaking research reveals that ibogaine, a unique psychedelic compound, shows promise in treating addiction. Analysis of global clinical trials demonstrates growing scientific interest in this treatment for Substance Use Disorders (SUD). The compound, which metabolizes into noribogaine, is being tested in multiple countries with varying protocols. Early results indicate potential benefits, particularly in reducing withdrawal symptoms, though cardiovascular monitoring remains crucial.
Abstract
Ibogaine, a non-classical psychedelic, has gained increasing attention as a potential treatment for substance use disorders (SUD); however, a lack ...
Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers.
Journal of psychopharmacology (Oxford, England) – April 18, 2025
Summary
A groundbreaking study reveals that microdosing LSD produces measurable effects in the body even at very low doses. Scientists tracked how the psychedelic compound moves through and affects the body (pharmacokinetics and pharmacodynamics) when taken sublingually. Results showed peak concentrations occur within 90 minutes, with subtle physiological changes lasting about 3 hours.
Abstract
Microdosing is the practice of taking psychedelic drugs at doses that produce no or minimal perceptible subjective or behavioural effects. This stu...
Characterization of responders to transcranial direct current stimulation in disorders of consciousness: A retrospective study of 8 clinical trials.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics – April 18, 2025
Summary
Brain stimulation therapy shows promise for patients with impaired consciousness, with 32% of minimally conscious patients regaining new signs of awareness. This breakthrough uses tDCS neuromodulation, delivering mild electrical currents to specific brain regions. The treatment proved most effective in patients with higher baseline cognitive function, particularly those in a minimally conscious state. Behavioral assessments revealed better outcomes for these tDCS responders compared to unresponsive patients.
Abstract
The treatment for patients with disorders of consciousness challenges researchers and clinicians. The stimulation of the left dorsolateral prefront...
Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.
Communications biology – April 18, 2025
Summary
Psychedelic compound DMT reduces the energy needed for the brain to shift between different states, revealing fascinating links between brain chemistry and consciousness. Researchers tracked brain activity in 14 people during brief but intense DMT experiences. The findings showed that DMT lowered the brain's "control energy" - the effort required to change neural patterns. These energy changes matched both participants' reported intensity of experience and measured increases in brain signal complexity. Notably, the effects were strongest in brain regions rich in serotonin receptors, suggesting a direct link between the drug's chemical action and its impact on consciousness.
Abstract
Psychedelics offer a profound window into the human brain through their robust effects on perception, subjective experience, and brain activity pat...
Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care
Palliative Medicine Reports – April 17, 2025
Summary
Psilocybin, a potent hallucinogen, shows promise in palliative care, enhancing quality of life by easing existential distress. Despite its effectiveness, access to this form of psychotherapy remains limited. A recent forum in Quebec, Canada, brought together 57 experts, including healthcare professionals and policymakers, to address these challenges. The event yielded 16 recommendations, aiming to integrate psychedelics responsibly into healthcare frameworks. This initiative helps expand access to vital mental health support, reflecting growing interest in Complementary and Alternative Medicine Studies and the potential of chemical synthesis and alkaloids in psychiatry.
Abstract
Psilocybin-assisted psychotherapy represents a promising addition to palliative care interventions, potentially improving quality of life by addres...
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis
Pharmacopsychiatry – April 17, 2025
Summary
Only four of eleven identified psilocybin clinical trial protocols for major depressive disorder (MDD) and treatment-resistant depression (TRD) adequately addressed regulatory standards. While superficially compliant, these trials, often using 25 mg of the alkaloid, overlooked critical drug interactions and potential biases like expectancy theory. Two protocols were double-blind. For psychiatry and psychology, ensuring rigorous oversight in medicine is crucial for psychedelics, understanding their neurotransmitter receptor influence. Patients with schizoaffective disorder were excluded, highlighting compliance gaps in these drug studies.
Abstract
Abstract Regulatory compliance is crucial in the clinical development of psychedelic substances, including psilocybin. This study aimed to examine ...
Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
Journal of Psychedelic Studies – April 17, 2025
Summary
Remarkably, meditation, psychedelics, and MDMA share common pathways for improving mental well-being. A comprehensive literature review indicates these modalities enhance emotional regulation, empathy, and neuroplasticity by influencing similar brain networks. Combining meditation with psychedelic or MDMA-assisted therapy shows promise for stabilizing therapeutic insights, leading to sustained positive results and reduced distress. This convergence offers a powerful new approach for mental health.
Abstract
AbstractBackground and aimsPsychedelic and MDMA-assisted psychotherapy are at the forefront of new treatment models for mental illnesses such as PT...
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
Schizophrenia Bulletin – April 17, 2025
Summary
Visual hallucinations, a core symptom in Lewy body diseases, astonishingly resemble those induced by psychedelics. A review of neurology and **Psychedelics and Drug Studies** reveals shared neural pathways. Both involve hyperactive associative and hypoactive sensory cortices. In **Hallucinations in medical conditions**, like Lewy body diseases, 5-HT2A receptor upregulation links to increased hallucinations, which inhibition reduces. **Complementary and Alternative Medicine Studies** also highlight serotonin 2A and 1A receptor modulation in psychedelic-induced experiences. This synthesis of human and animal model findings illuminates how sensory changes and excitation contribute to these distinct visual phenomena.
Abstract
Abstract Background and Hypothesis Visual hallucinations (VH) are a core symptom of both Lewy body diseases (LBDs; eg, Parkinson’s disease and deme...
Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus
Journal of Psychopharmacology – April 17, 2025
Summary
A single dose of the hallucinogen psilocybin dramatically alters brain chemistry. In a pilot study on male Wistar–Han rats, a 10 mg/kg dose of psilocybin increased the expression of most neuropeptides and specific serotonin 5-HT receptors (5-HT1A, 5-HT2A, 5-HT2B) within the hypothalamus. This neurochemical shift, observed in Neuroscience and Pharmacology, suggests how psilocybin, a key compound in Psychedelics and Drug Studies, influences neurotransmitter receptor activity. Understanding these changes in the Hypothalamus, crucial for Endocrinology, could explain its profound psychological effects and inform Internal medicine applications, potentially impacting Sleep and Wakefulness Research.
Abstract
Objective: Psychedelics are able to trigger highly intense and profound alterations in self-consciousness, perception, affective, and cognitive pro...
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity.
Trials – April 17, 2025
Summary
Ketamine shows promising rapid relief for patients battling both depression and opioid addiction. In a groundbreaking clinical trial, ketamine outperformed buprenorphine in quickly reducing both anxiety and drug cravings. While buprenorphine provided gradual improvement over days, ketamine delivered significant relief within hours. This dual-action approach offers new hope for treating these challenging co-occurring conditions.
Abstract
The concomitant presence of major depressive disorder (MDD) and opioid use disorder (OUD) poses a formidable clinical challenge, warranting effecti...
Consumer-Grade Neurofeedback With Mindfulness Meditation: Meta-Analysis.
Journal of medical Internet research – April 17, 2025
Summary
No Summary
Abstract
There is burgeoning interest in the application of neuroscientific technology to facilitate meditation and lead to beneficial psychological outcome...
Psilocybin biosynthesis enhancement through gene source optimization.
Metabolic engineering – April 16, 2025
Summary
Scientists achieved record-breaking production of psilocybin by mixing and matching genes from different mushroom species. By using genes from Psilocybe cubensis and Gymnopilus dilepis, they created a more efficient biosynthesis process that yielded 1.46 g/L of psilocybin - the highest ever recorded. This breakthrough could make it easier to produce this promising mental health treatment.
Abstract
Psilocybin, the prodrug to the psychoactive compound in 'magic' mushrooms, is currently being studied in clinical trials as a treatment for severe ...
Ayahuasca Retreats: The Role of Awe and Mystical Experiences in Well-Being.
Journal of psychoactive drugs – April 16, 2025
Summary
Profound mystical experiences during ayahuasca retreats can significantly impact well-being, but not always in expected ways. Researchers tracked 60 participants who attended legal retreats, finding that the most positive outcomes occurred when people reported deep mystical experiences without feeling overwhelmed by the vastness of their psychedelic journey. This suggests that balanced, manageable experiences may be key to transformation.
Abstract
Research on the positive psychological effects of psychedelics has surged since the early 2000s, particularly regarding increased well-being. Studi...
Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self
Imaging Neuroscience – April 16, 2025
Summary
Our sense of time and self can profoundly shift under altered states. Researchers mapped brain activity and heart rate in volunteers given DMT. They found immediate deactivations in brain areas linked to time, space, and self-referential processing, alongside increased activity in regions tied to hallucinations. Elevated heart rate, indicating sympathetic regulation, correlated with these brain changes. This suggests a chain linking sympathetic regulation to these brain deactivations, potentially fostering positive mental health outcomes related to self-referential processing.
Abstract
Abstract N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic, known to rapidly induce short-lasting alterations in conscious experience, cha...
Prehospital Ketamine Administration in Benzodiazepine Refractory Status Epilepticus: A Case Series Review.
Prehospital emergency care – April 16, 2025
Summary
When seizures don't respond to standard treatments, ketamine shows remarkable promise, stopping seizures in over 90% of cases. This medication, already used by emergency responders for other conditions, proved highly effective when given to 42 patients whose seizures weren't controlled by conventional drugs. While some patients needed breathing support, the success rate suggests ketamine could be a game-changing option for emergency treatment of persistent seizures.
Abstract
Benzodiazepines are the treatment for seizures in prehospital settings, but fail in up to 40% of cases, leading to benzodiazepine refractory status...
Nursing care in ketamine infusions for pain control in adults: a scoping review protocol.
JBI evidence synthesis – April 16, 2025
Summary
Healthcare providers are increasingly turning to intravenous ketamine for innovative pain management, with nurses playing a crucial frontline role. This comprehensive analysis examines how nursing practice impacts patient care during ketamine treatments, from initial patient assessment through monitoring and education. The review spans multiple databases to understand best practices in both hospital and outpatient settings, focusing on safe administration protocols and effective pain management strategies. Results will help standardize nursing care for ketamine infusion therapy.
Abstract
This scoping review will map the available evidence on nursing care provided to adults receiving ketamine infusion for pain management in hospitals...
Radiation Therapy Patients’ Interest in Psychedelic-assisted Therapy: A Prospective Survey Study
Research Square – April 16, 2025
Summary
Many cancer patients receiving radiation therapy are keen on psychedelic-assisted therapy. This signals a promising new avenue for managing distress and boosting well-being. A survey found most radiation patients open to these novel approaches, especially those with higher anxiety or depression, viewing them as valuable for improving mental health. Patients clearly seek emotional support in cancer care.
Abstract
Radiation Therapy Patients’ Interest in Psychedelic-assisted Therapy: A Prospective Survey Study
The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies.
Biological psychiatry – April 15, 2025
Summary
Intravenous ketamine shows promise in rapidly shifting how depressed patients process emotional information. Research reveals that a single ketamine dose significantly reduces negative attention patterns within 24 hours. This rapid-acting antidepressant not only improves mood but also changes how the brain focuses on sad versus neutral information. Testing across multiple patient groups confirmed these results, demonstrating both the treatment's reliability and its ability to quickly alter attentional bias in depression.
Abstract
Ketamine is known for its rapid antidepressant effect, but its impact on affective information processing (including attentional bias [AB], a putat...
A Low Life's Simple 7 Score Is an Independent Risk Factor for Postoperative Delirium After Total Knee Arthroplasty.
Medicina (Kaunas, Lithuania) – April 15, 2025
Summary
A simple heart health score could predict mental confusion risks after knee surgery. Researchers found that patients with lower Life's Simple 7 scores were more likely to experience postoperative delirium after total knee arthroplasty. This easy-to-measure cardiovascular health metric helps doctors identify at-risk patients and provide better care planning for knee replacement procedures.
Abstract
Background and Objectives: Postoperative delirium (PODil) is a cognitive condition characterized by sudden fluctuations in consciousness and orient...
Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway.
Naunyn-Schmiedeberg's archives of pharmacology – April 15, 2025
Summary
Psilocin, the active compound in psychedelic mushrooms, shows promise in treating severe itching. In groundbreaking research with mice, this compound significantly reduced scratching behavior by interacting with specific brain receptors and the kynurenine pathway. The treatment was most effective when combined with another compound, suggesting a potential new approach for treating chronic itch conditions.
Abstract
We aimed to investigate whether psilocin, the bioactive metabolite of the well-known psychedelic, psilocybin, may have antipruritic effects in mice...
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential
Proceedings of the National Academy of Sciences – April 14, 2025
Summary
Neuroscience offers hope for disorders. Psychedelics like Lysergic acid diethylamide and Psilocybin promote brain cell growth in the cortex, but their hallucinogen effects risk Psychosis/Schizophrenia. Through chemical synthesis, a new alkaloid (+)-JRT emerged. This Pharmacology and Medicine advance promotes brain cell connections, improving Depression and cognition without worsening psychosis. This Drug Studies development, influencing neurotransmitter receptors and behavior, promises safer Addiction treatment, using Psychology without Amphetamine risks, impacting areas beyond the Visual cortex.
Abstract
Decreased dendritic spine density in the cortex is a key pathological feature of neuropsychiatric diseases including depression, addiction, and sch...
PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and Behaviour
OpenAlex – April 14, 2025
Summary
A major Neuroimaging effort is exploring how the hallucinogen psilocybin impacts the brain and mind. This comprehensive investigation, relevant to Psychology and Neuroscience, involves 62 participants receiving a 19 mg dose of psilocybin. Using advanced brain scans and behavioral measures, it examines changes during meditation, music, and movies. Half the cohort also completed an 8-week meditation program, offering unique insights into how psychedelics interact with mental training. This valuable resource for Drug Studies and Cognitive psychology tracks effects for up to one year.
Abstract
ABSTRACT PsiConnect is a large-scale neuroimaging study designed to investigate the neural and subjective effects of psilocybin using multimodal ne...
The 50% effective dose of remimazolam combined with different doses of esketamine for painless gastroscopy.
Scientific reports – April 14, 2025
Summary
A breakthrough in painless gastroscopy reveals that combining remimazolam with esketamine significantly reduces the medication dose needed for effective sedation. This medical advance helps doctors perform gastrointestinal endoscopy procedures more safely. The optimal combination found that adding esketamine cut the required remimazolam dose by nearly half, while providing better stability and fewer side effects.
Abstract
Remimazolam is a novel benzodiazepine sedative that provides effective sedation, stable haemodynamics, and minimal adverse effects during intraveno...
Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice
OpenAlex – April 14, 2025
Summary
Prolonged low-dose LSD, a focus in Psychedelics and Drug Studies, revealed no cardiovascular risk in mice. Using Biochemical Analysis and Sensing Techniques, heart health was monitored after chronic administration of very low doses. While serotonin, known to activate specific neurotransmitter receptors linked to heart issues, caused significant heart wall thickening at 4 and 8 weeks, LSD groups showed no such changes. Pharmacology indicated LSD's influence on these receptors was substantial but brief, unlike heart-damaging substances. This offers critical Medicine insights into microdosed psychedelics' safety profile and Neurotransmitter Receptor Influence on Behavior.
Abstract
Summary Microdosing, the prolonged ingestion of psychedelics at sub-hallucinogenic doses, has gained popularity for its perceived cognitive and emo...
A Categorical Model of General Consciousness.
Biomimetics (Basel, Switzerland) – April 14, 2025
Summary
A breakthrough mathematical approach reveals how consciousness emerges from neural networks through recursive patterns. By mapping the relationships between physical brain states and conscious experiences, researchers demonstrated how general consciousness arises through distinct layers of processing. The model shows consciousness operates like a specialized Turing machine, with cognizance emerging from homomorphic patterns in neural networks.
Abstract
Consciousness is liable to not be defined in scientific research, because it is an object of study in philosophy too, which actually hinders the in...
Quantum information theoretic approach to the hard problem of consciousness
arXiv Preprint Archive – April 13, 2025
Summary
Consciousness might be fundamentally quantum, not classical, in nature. New research in q-bio.NC reveals how quantum mechanics could explain subjective experience - something traditional brain theories struggle with. By linking consciousness to quantum states rather than classical brain activity, this framework explains why our inner experiences feel unique and irreducible to physical processes.
Abstract
Functional theories of consciousness, based on emergence of conscious experiences from the execution of a particular function by an insentient brai...
Decreasing Workplace Violence With-Injury in an Acute Psychiatric Setting Through Brief Intentional Grounding.
Journal of holistic nursing : official journal of the American Holistic Nurses' Association – April 13, 2025
Summary
No Summary
Abstract
Purpose: The purpose of this study is to evaluate if integrating a holistic mindfulness modality into group therapy can decrease violence with-inju...
Saberes da ayahuasca e processos educativos na religião do Santo Daime
Revista Latinoamericana de Ciencias Sociales Niñez y Juventud – April 13, 2025
Summary
Ayahuasca is celebrated not just as a psychedelic experience but as a profound educational journey. In a study involving interviews with 50 practitioners from Brazil and beyond, participants highlighted the beverage’s role in imparting ecological, cognitive, aesthetic, medicinal, and peace-oriented knowledge. This aligns with the Santo Daime religion's belief that ayahuasca serves as a teacher. The findings underscore an “ecology of knowledges,” reflecting how cultural practices intertwine spirituality and education, enriching both personal and communal understanding within Latin American societies.
Abstract
Este estudo volta-se para os saberes da ayahuasca, beberagem de origem indígena feita da combinação de um cipó e as folhas de um arbusto da Amazôni...
Decreased CO<sub>2</sub> saturation during circular breathwork supports emergence of altered states of consciousness.
Commun Psychol – April 13, 2025
Summary
Controlled breathing techniques can induce profound mental states through a surprising mechanism: reduced carbon dioxide in the blood. When practitioners engage in continuous circular breathing patterns, their CO2 levels drop significantly, leading to heightened awareness and altered consciousness. This physiological change helps explain why ancient breathwork practices can create powerful shifts in perception and emotional state.
Abstract
Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness.
N1 cassette-lacking NMDA receptors mediate the antidepressant activity of ketamine
bioRxiv Preprint Server – April 12, 2025
Summary
A key to ketamine's rapid antidepressant effect lies in specific brain receptors. Research shows that a particular variant of NMDA receptors, called GluN1a, is crucial. When these GluN1a receptors are present, ketamine effectively blocks their activity, especially during intense brain signals. This blockade leads to a positive antidepressant outcome. Conversely, when a different receptor variant is present, ketamine has no such effect. This pinpoints GluN1a receptors as essential targets for ketamine's powerful mood-lifting properties.
Abstract
Ketamine has emerged as a rapid-acting and robust antidepressant1,2. However, the mechanism of its antidepressant action remains enigmatic. The cor...
Etomidate vs Ketamine-Propofol for Induction of Anesthesia in Coronary Artery Bypass Grafting: An Updated Systematic Review and Meta-Analysis.
Seminars in cardiothoracic and vascular anesthesia – April 12, 2025
Summary
When preparing patients for coronary artery bypass surgery, choosing the right anesthetic combination is crucial. New research shows that etomidate maintains better blood pressure stability compared to ketofol (a ketamine-propofol mix) during anesthetic induction. However, both medications proved equally effective, requiring similar levels of medical intervention to manage blood pressure changes during the procedure.
Abstract
Background: Etomidate has minimal cardiovascular depressant effects at the cost of endogenous cortisol production suppression, whereas propofol has...
The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity.
Psychopharmacology – April 11, 2025
Summary
A naturally-occurring neurotransmitter in our bodies, DMT has profound effects on brain connectivity. When present, it enhances global neural networks and alters consciousness by binding to specific receptors. Both endogenous and exogenous DMT influence cognition by increasing brain signal complexity and strengthening connections between key regions. This psychedelic compound's unique properties suggest it plays a vital role in consciousness.
Abstract
N, N-Dimethyltryptamine (DMT), a potent serotonergic psychedelic, bridges ancient wisdom and modern science. The mechanisms underlying its powerful...
Less is better: role of adjuvants.
Current opinion in anaesthesiology – April 11, 2025
Summary
Adding certain medications to local anaesthetics can significantly enhance pain control during regional anaesthesia. Recent evidence shows that carefully chosen adjuvants can boost the effectiveness of peripheral nerve blocks while reducing the amount of anaesthetic needed. Dexamethasone and dexmedetomidine stand out as promising options, with dexamethasone showing particularly strong results. This approach offers better pain management with lower medication doses.
Abstract
To update published data about adjuvants and examine their evolution in use over the last 2 years. This scoping review highlights current and updat...
Unveiling Reality: Psychedelics, Neural Filtering, and the Future of Psychiatric Medicine.
ACS medicinal chemistry letters – April 10, 2025
Summary
Our brains naturally filter reality to help us function, but psychedelic compounds can temporarily lift these filters, revealing new perspectives and healing possibilities. Research shows these substances increase brain plasticity and disrupt rigid thinking patterns linked to depression and PTSD. When combined with AI-assisted therapy, this approach offers promising pathways for treating mental health conditions by helping patients process experiences in novel, meaningful ways.
Abstract
Psychedelics and AI modulate cognitive frameworks, disrupt rigid thought patterns, and enhance neuroplasticity, offering therapeutic potential for ...
Effect of Esketamine on Postoperative Delirium and Inflammatory Response in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Study.
Journal of cardiothoracic and vascular anesthesia – April 10, 2025
Summary
A breakthrough in heart surgery recovery shows that esketamine, administered during off-pump coronary bypass procedures, cuts the risk of post-surgery confusion by over 50%. The medication not only reduced postoperative delirium but also lowered inflammation markers significantly. This advancement offers cardiac patients better recovery outcomes with fewer mental complications.
Abstract
To investigate whether continuous intravenous infusion of esketamine during surgery can improve postoperative delirium (POD) and inflammatory respo...
Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.
Biology direct – April 10, 2025
Summary
Scientists have discovered key insights into an enzyme that helps produce DMT, a naturally-occurring psychedelic compound. Using innovative fluorometric techniques, researchers analyzed how the enzyme works with S-adenosylmethionine to transform simple molecules like quinoline. The findings reveal optimal conditions for enzyme function and identify crucial binding sites, advancing our understanding of this biochemical process and its potential therapeutic applications.
Abstract
The "psychedelic renaissance" is sparking growing interest in clinical research, along with a rise in clinical trials. Substances such as 3,4-methy...
Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach
Preprints.org – April 10, 2025
Summary
Psilocybin, a potent hallucinogen, shows compelling promise in palliative care, offering a new frontier in medicine. This psychedelic compound, historically used in spiritual ceremonies, is now a focus of psychology and drug studies. Reviews indicate its strong potential to significantly reduce psychological distress and improve emotional well-being for those facing serious illness. Understanding its pharmacokinetics and chemical structure is vital. Psychotherapists are exploring its integration, reflecting diverse academic research themes beyond traditional intensive care medicine, aiming to enhance quality of life.
Abstract
Psilocybin, a psychedelic compound in certain mushrooms, has been used for centuries in spiritual ceremonies and neuropsychiatric therapy. Despite ...
The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage.
International journal of molecular sciences – April 10, 2025
Summary
Ketamine shows promise in treating depression even when liver problems are present - a crucial finding for millions affected by both conditions. In mice with fatty liver disease (NAFLD) and depression-like symptoms, ketamine effectively reduced depressive behaviors and anxiety, particularly in older subjects. The treatment improved social interaction and mood without worsening liver health, though memory benefits were limited in animals with liver damage. These results suggest ketamine could be valuable for patients dealing with both depression and liver conditions.
Abstract
Non-alcoholic fatty liver disease (NAFLD) has been associated with depression and inadequate response to antidepressants. While ketamine has demons...
Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies
ACS Medicinal Chemistry Letters – April 10, 2025
Summary
Psilocybin offers a clinically meaningful reduction in phantom and residual limb pain, marking a significant advance in Pain Management and Physical Medicine and Rehabilitation. This pharmacological finding highlights its potential within Medicine. Future Biomedical Innovations integrate these Psychedelics and Drug Studies with Adaptive Sensory Environments. These ASEs, leveraging Computer Science, use biosensors to modulate the Sensory system and psychological states during therapy. This approach aims for precision and scale in interventions, prompting considerations for Neuroethics and Human Enhancement in optimizing therapeutic benefits.
Abstract
Psilocybin demonstrates a clinically meaningful reduction in phantom and residual limb pain. Adaptive sensory environments (ASEs) separately offer ...
Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine.
ACS medicinal chemistry letters – April 10, 2025
Summary
No Summary
Abstract
Recent advancements in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI-powered machine-learning platforms mark a ...
Learning and language in the unconscious human hippocampus.
bioRxiv : the preprint server for biology – April 09, 2025
Summary
Your brain keeps learning, even when you're completely unconscious. Scientists discovered that hippocampal neurons - our brain's memory center - can detect unusual sounds and process language during general anesthesia. Using advanced recording techniques, they found these neurons not only recognize patterns but also predict upcoming words, suggesting complex information processing continues even without consciousness.
Abstract
Consciousness is a fundamental component of cognition, 1 but the degree to which higher-order perception relies on it remains disputed. 2,3 Here we...
The Emergence of Psilocybin in Psychiatry and Neuroscience
Pharmaceuticals – April 09, 2025
Summary
Psilocybin, a potent hallucinogen, is showing compelling promise in Psychiatry and Medicine. Emerging evidence from clinical trials supports its efficacy for conditions like Major depressive disorder and anxiety. This psychedelic compound, whose therapeutic action involves Neurotransmitter Receptor Influence on Behavior, offers new avenues in Psychology. Advances in Chemical synthesis and alkaloids are vital for broader access. As Psychedelics and Drug Studies progress, careful integration is key to realizing psilocybin's potential.
Abstract
Psilocybin, a naturally occurring psychedelic compound, has garnered renewed scientific interest for its potential in treating psychiatric and neur...
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology – April 09, 2025
Summary
In a groundbreaking development, psilocybin therapy shows promise for improving both mental and physical symptoms in Parkinson's disease patients. Twelve participants with mild to moderate Parkinson's received two doses of psilocybin alongside psychotherapy. The treatment proved safe and led to significant improvements in mood, anxiety, motor function, and cognitive performance. Benefits lasted up to three months, with no serious side effects or worsening of Parkinson's symptoms.
Abstract
Mood dysfunction is highly prevalent in Parkinson's disease (PD), a main predictor of functional decline, and difficult to treat-novel intervention...
In Vitro Psilocybin Synthesis by Co‐Immobilized Enzymes
Chemistry - A European Journal – April 09, 2025
Summary
A new biochemical approach achieves quantitative turnover of a precursor into psilocybin, a crucial compound for treating major depressive disorder in Psychedelics and Drug Studies. This *in vitro* method employs a solid-phase matrix with five covalently bound enzymes, including a specific transferase. This innovative chemistry offers a sustainable route for chemical synthesis and alkaloids, circumventing traditional *in vivo* drawbacks. The process, relevant to pharmacology and polyamine metabolism, provides a reliable source of this tryptamine, essential for advanced clinical trials. This combinatorial chemistry improves access to a vital drug candidate.
Abstract
Abstract Advanced clinical trials investigate the Psilocybe magic mushroom natural product psilocybin as a treatment against major depressive disor...
A multi-institutional investigation of psilocybin’s effects on mouse behavior
OpenAlex – April 09, 2025
Summary
A rigorous multi-lab study on the hallucinogen psilocybin, a compound related to tryptophan, revealed surprising acute effects on mouse behavior. Across five labs using ~200 mice, psilocybin acutely increased anxiety but decreased fear expression. However, 24 hours later, this drug, influencing neurotransmitter receptors, showed no replicable persistent effects on reducing anxiety or depression-like behaviors, including anhedonia, or facilitating fear extinction. This finding in psychology and drug studies suggests psilocybin's long-term efficacy for conditions like social anxiety, impacting clinical and developmental psychology, might be less consistent in mice.
Abstract
ABSTRACT Studies reporting novel therapeutic effects of psychedelic drugs are rapidly emerging. However, the reproducibility and reliability of the...
The Impact of Morning Meditation and Sleep Quality on Affective and Health Outcomes in Healthcare Workers.
International journal of environmental research and public health – April 09, 2025
Summary
Healthcare workers who start their day with meditation show remarkable benefits, especially after a poor night's sleep. Morning meditation practices boost positive mood and vitality throughout the workday, with the strongest effects seen in those who didn't sleep well. This micro-break strategy proves particularly powerful for mental health, helping staff maintain energy and emotional balance despite sleep challenges.
Abstract
Health is a critical factor influencing key workplace outcomes, including job attitudes, behaviors, and performance. This study investigated the ro...
Ketamine for acute management of refractory stiff person syndrome: a case report.
BMC neurology – April 09, 2025
Summary
A breakthrough in treating Stiff Person Syndrome shows ketamine can effectively manage severe muscle rigidity and painful spasms when traditional treatments fail. In a remarkable case, doctors successfully used ketamine infusions to provide rapid relief for a young patient with debilitating symptoms. This novel approach not only reduced pain and anxiety but also helped control muscle stiffness during acute flares.
Abstract
Stiff Person Syndrome (SPS) is a rare autoimmune neurological disorder characterized by progressive muscle rigidity and painful spasms. Standard tr...
Sex specific effects of ketamine, but not other glutamate receptor modulators, on ethanol self-administration and reinstatement of ethanol seeking in rats.
Psychopharmacology – April 08, 2025
Summary
Female rats showed unique responses to ketamine in reducing alcohol consumption, revealing important sex differences in addiction treatment. The research explored how ketamine and similar drugs affect alcohol-seeking behavior in rats under stress conditions. While ketamine significantly reduced alcohol consumption in females at specific doses, it had minimal effect in males. Interestingly, memantine worked for both sexes, while hydroxynorketamine showed no impact. These findings suggest sex-specific approaches may be crucial for treating alcohol disorders.
Abstract
Alcohol use and major depressive disorder are frequently comorbid, with individuals diagnosed with a substance use disorder being nearly three time...
Impact of esketamine intravenous analgesic pump on pain and depression post-cesarean.
BMC surgery – April 08, 2025
Summary
New research shows esketamine delivered through an IV pump significantly improves recovery after cesarean sections. Women receiving this treatment experienced less postoperative pain and showed lower rates of postpartum depression compared to traditional pain management. The treatment also led to faster recovery times and easier breastfeeding initiation, without increasing side effects.
Abstract
Postoperative pain and psychological well-being in postpartum women following cesarean section are critical for optimal maternal recovery. Traditio...
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood.
Psychopharmacology bulletin – April 08, 2025
Summary
A decade-long journey shows how innovative treatments can help overcome severe depression. A patient battling treatment-resistant depression and multiple mental health comorbidities found lasting stability through a combination of therapies. While electroconvulsive therapy offered temporary relief, ketamine and esketamine treatments proved most effective, leading to two years without hospitalization or crisis - marking a significant breakthrough in managing complex depression.
Abstract
In this case report, we present a patient with treatment-resistant depression (TRD) and comorbid generalized anxiety disorder, eating disorder, pos...
Mindfulness enhancements predict aberrant salience reductions and improve stress management.
Discover mental health – April 08, 2025
Summary
Regular mindfulness practice can dramatically reduce our tendency to overreact to daily stressors. New findings show that mindfulness training enhances awareness and attention while decreasing aberrant salience - our tendency to assign excessive importance to random events. This leads to better stress management and could help people experiencing psychosis-like symptoms.
Abstract
Mindfulness improves mental health and clinical conditions including psychosis and modulates attentional processes including salience-the automatic...
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization.
Front Psychiatry – April 08, 2025
Summary
Psychedelic therapy's success may depend more on therapeutic support than previously thought. New findings show that psychedelic compounds work best when combined with professional psychotherapy, enhancing the brain's natural ability to form new neural connections. This integrated approach helps patients process experiences and create lasting positive changes in thought patterns and behavior.
Abstract
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization.
Dated Phylogeny of Banisteriopsis (Malpighiaceae) Suggests an Ancient Colonization of the Cerrado and No Evidence of Human Manipulation in the Origin of B. caapi.
Plants (Basel, Switzerland) – April 07, 2025
Summary
The ancient vine used in Ayahuasca ceremonies has deeper roots than previously thought. DNA analysis reveals that Banisteriopsis plants colonized South America's Cerrado grasslands 22 million years ago, long before humans. This finding, based on detailed phylogenetics, shows how these plants spread throughout the Neotropics, naturally evolving without human intervention. The research challenges assumptions about indigenous peoples' role in the plant's development.
Abstract
Banisteriopsis is a genus in the Malpighiaceae family with 61 species, notable for including ritualistic taxa such as B. caapi (Spruce ex Griseb.) ...
The compulsive eating paradigm: can psychedelics help in treating obesity?
Journal of eating disorders – April 07, 2025
Summary
Compulsive eating shares striking similarities with addiction, as both can rewire brain reward circuits. Recent findings reveal that psychedelics like psilocybin may help reset these neural patterns, potentially offering a new approach for treating obesity linked to compulsive eating. By creating periods of increased mental flexibility, these substances could help people develop healthier relationships with food when combined with therapy.
Abstract
Obesity is a multifactorial disorder involving a behavioural aetiology in subsets of patients that traditional therapeutic approaches have failed t...